Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harvard Dental International is a German dental materials company focused on the development, production, and commercialization of products used in restorative dentistry, endodontics, and prosthetics. The company traces its brand heritage to 1892, when Robert Richter introduced Harvard Cement and founded the original Harvard Dental Compagnie in Berlin. Today, Harvard markets a portfolio that includes dental cements, composites, adhesives, impression materials, root canal materials, and MTA-based endodontic products, with manufacturing in Germany. It operates as a commercial-stage oral healthcare supplier rather than a drug-development biotech company, serving dentists and dental laboratories with established dental consumables and treatment materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harvard Dental International.